Status:
COMPLETED
The Significance of Funguria in Hospitalized Patients
Lead Sponsor:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Cedars-Sinai Medical Center
Conditions:
Urinary Tract Infections
Eligibility:
All Genders
Brief Summary
This investigation is a epidemiologic case-control study of the risk factors associated with nosocomial funguria (fungi in the urine).
Detailed Description
A recent large multi-center national surveillance survey of almost 5000 nosocomial (hospital based) urine isolates from medical intensive care units demonstrated that fungi comprised nearly 40% of uri...
Eligibility Criteria
Inclusion
- Patients hospitalized at least 12 hours of any age (\< 1 day to \> 100 years of age) AND a urine or blood culture positive for fungi, OR urine culture negative for fungi (control group)
Exclusion
- Patients already surveyed for funguria during current hospitalization and patients already being followed for recognized funguria
Key Trial Info
Start Date :
September 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
919 Patients enrolled
Trial Details
Trial ID
NCT00787085
Start Date
September 1 2001
End Date
February 1 2006
Last Update
November 7 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
2
Harbor-UCLA Medical Center
Torrance, California, United States, 90509